๐น IN-DEPTH SCIENTIFIC PROFILE
AHK-Cu is the synthetic tripeptide Ala-His-Lys (Alanyl-Histidyl-Lysine) complexed with copper (II), presented as a 100 mg lyophilized research vial. The literature documents it in hair follicle and dermal matrix studies as a copper complex associated with cell proliferation signaling.
Signaling pathways documented in the literature:
- Follicle stimulation Ex vivo models of human hair follicles document elongation and proliferation of dermal papilla cells
- Copper Signaling: The copper (II) complex is associated in literature with extracellular matrix modulation and dermal angiogenesis
๐ฌ DOCUMENTED SCIENTIFIC EVIDENCE
- Pyo HK et al., Biol Pharm Bull 2007 (PMID 17703734): AHK-Cu in in vitro human hair follicle growth and dermal papilla cell proliferation studies
- Pickart L, Margolina A, Int J Mol Sci 2018 (PMID 30041448): Copper peptide review in dermal remodeling and extracellular matrix
Research material only. No FDA-approved human use. Information is provided for educational and scientific literature reference purposes.
โ๏ธ TECHNICAL SPECIFICATIONS
- Identification: AHK-Cu โ Alanine-Histidine-Lysine tripeptide complexed with copper (II)
- Presentation 100 mg lyophilized per vial
- Purity >98% by HPLC
- Laboratory reconstitution: 2 ml bacteriostatic water โ 50,000 mcg/ml solution
- Conservation lyophilized
refrigerated 2-8ยฐC
protect from light (photosensitive copper complex)
use within 28 days after reconstitution
- Aspect Light blue freeze-dried powder (characteristic color of complexed copper)
๐ RECOMMENDED USE
Material intended exclusively for scientific research.
Not for human consumption. No FDA-approved human use. Information is provided for educational and reference purposes to the published scientific literature.
Research material only. This product is intended for scientific research in controlled laboratory settings only. It is not a drug. Not for human or animal use, not for diagnostic or therapeutic use. No FDA-approved human use.